Cadence Neuroscience

United States
Melba, Idaho, United States, 98052

Company profile

Cadence Neuroscience company profile

Cadence Neuroscience is an early-stage company developing new medical device therapies for the treatment of epilepsy, central pain, and other neurological disorders. The company's core technology has been developed at Mayo Clinic and is under clinical evaluation. Its medical device therapies provide medical practitioners with a procedure that can be used to tailor brain stimulation therapy to each individual and enhance seizure control compared to currently used protocols. Cadence Neuroscience was established in 2017 and is headquartered in Redmond, Washington.

Business identity

Phone number
425-681-6863
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2017-01-01, Year

Headquarters

Postal code
98052
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
3
Total equity funding
$41M
Last funding
Series B / $26M / 2023-02-28
Last equity funding
Series B / $26M
Investors
8
Lead investors
3
Founders
2
Articles
2

Founders and investors

Founders

Doug SheffieldKent Leyde

Lead investors

Angelini Lumira Biosciences FundEpilepsyJazz Venture Partners

Investors

Angelini VenturesF-PrimeJazz Venture PartnersLivaNovaMayo Clinic